• I Wayan Putu Sutirta-Yasa
  • Gede Agus Eka Tirta Putra
  • Ana Rahmawati


The incidence and geographical distribution of dengue has gradually increased during the past decade. Today, dengue is considered one of the most important arthropod-borne viral diseasases in humans in term of morbidity and mortality. Dengue infection   a potential life-threatening dengue hemorrhagic fever (DHF) / dengue shock syndrome(DSS), characterized by thrombocytopenia and increased vascular permiability. Thrombocytopenia causes bleeding, but in   DHF patients with thrombocytopenia do not always develop bleeding manifestation. The pathogenesis of thrombocytopenia are not cleared. Multiple factors  may be involved in the machanisms leading to thrombocytopenia in DHF/DSS patients.

Author Biographies

I Wayan Putu Sutirta-Yasa
SMF/Bagian Patologi Klinik Fak. Kedokteran Universitas Udayana/RSUP Sanglah Denpasar,  dan Dosen Program Studi S3/doktor Ilmu Kedokteran Pascasarjana Universitas Udayana
Gede Agus Eka Tirta Putra
Puskesmas Karangasem 2
Ana Rahmawati
Rumah Sakit Surya Usada Denpasar
How to Cite
SUTIRTA-YASA, I Wayan Putu; TIRTA PUTRA, Gede Agus Eka; RAHMAWATI, Ana. THROMBOCYTOPENIA IN DENGUE HAEMORRHAGIC FEVER. Medicina, [S.l.], v. 43, n. 2, apr. 2013. ISSN 2540-8321. Available at: <>. Date accessed: 19 nov. 2019.


dengue hemorrhagic fevers, dengue shock syndrome, thrombocytopenia